ChiCTR2300076931 版本V1.1 版本创建时间2024/04/30 21:19:12 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300076931 

最近更新日期:

Date of Last Refreshed on:

2023-10-24 16:18:20 

注册时间:

Date of Registration:

2023-10-24 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

Public title:

MOVIN' CARE for PD (Mind-body interventions)

注册题目简写:

English Acronym:

研究课题的正式科学名称:

Scientific title:

MOVIN' CARE for PD: A Project on Community Awareness, Rehabilitation and Empowerment for Parkinson’s Disease (Mind-body interventions)

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

 

研究负责人:

 

Applicant:

Charis Ann Lai 

Study leader:

Jojo Yan Yan Kwok 

申请注册联系人电话:

Applicant telephone:

+852 3917 9861

研究负责人电话:

Study leader's telephone:

+852 3917 6644

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

charisal@hku.hk

研究负责人电子邮件:

Study leader's E-mail:

jojoyyk@hku.hk

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

研究负责人通讯地址:

Applicant address:

5/F, Academic Building, 3 Sassoon Road, Pokfulam, Hong Kong

Study leader's address:

5/F, Academic Building, 3 Sassoon Road, Pokfulam, Hong Kong

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

Applicant's institution:

The University of Hong Kong

研究负责人所在单位:

Affiliation of the Leader:

The University of Hong Kong

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

EA2306262

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

Name of the ethic committee:

Human Research Ethics Committee (HREC)

伦理委员会批准日期:

Date of approved by ethic committee:

2023-06-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

Becky Wong

伦理委员会联系地址:

Contact Address of the ethic committee:

9/F Knowles Building, the University of Hong Kong

伦理委员会联系人电话:

Contact phone of the ethic committee:

+852 2241 5267

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

Primary sponsor:

The Hong Kong Jockey Club

研究实施负责(组长)单位地址:

Primary sponsor's address:

One Sports Road, Happy Valley, Hong Kong

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

省(直辖市):

市(区县):

Country:

China

Province:

Hong Kong

City:

单位(医院):

具体地址:

Institution
hospital:

The Hong Kong Jockey Club

Address:

One Sports Road, Happy Valley, Hong Kong

经费或物资来源:

Source(s) of funding:

The Hong Kong Jockey Club Charities Trust

Target disease:

Parkinson's disease

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

 

Objectives of Study:

The study of component two aims to investigate the effectiveness of two mind-body interventions - yoga, and arts-based approaches in improving the psycho-social-spiritual well-being among PD patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

Adults who are 1) diagnosed with idiopathic, mild-to-advance PD as indicated by Hoehn and Yahr Scale Stage I to IV (those with unilateral/bilateral symptoms, with/without postural instability who are able to walk at least 3 meters or stand unassisted); 2) aged 18 or above; 3) able to give written informed consent; 4) able to access to the internet and smartphone/ tablet/ laptop will be included; 5) able to comprehend Chinese will be included.

排除标准:

Exclusion criteria:

The exclusion criteria are state as follows: 1) participants have significant cognitive impairment as indicated by the Abbreviated Mental Test lower than 6 significant; 2) participants have been regularly engaged in regular instructor-led mind-body exercise (e.g., Taichi) or arts-based therapies (>2 times per week) in the past 3 months ; 3) currently participating in any other behavioral or pharmacological trial; 4) participants have other contraindication(s) that may limit their full participation (e.g. severe hearing or vision impairment, etc.).

研究实施时间:

Study execute time:

From 2023-09-18 00:00:00 To 2028-05-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-10-27 00:00:00 To 2028-05-31 00:00:00  

干预措施:

Interventions:

组别:

样本量:

77

Group:

Mind-body intervention A

Sample size:

干预措施:

干预措施代码:

Intervention:

Yoga intervention

Intervention code:

组别:

样本量:

77

Group:

Mind-body intervention B

Sample size:

干预措施:

干预措施代码:

Intervention:

Arts-based intervention

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

省(直辖市):

 

市(区县):

 

Country:

China 

Province:

Hong Kong 

City:

 

单位(医院):

 

单位级别:

 

Institution
hospital:

The University of Hong Kong

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

指标类型:

主要指标

Outcome:

Change of perceived stress level

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

主要指标

Outcome:

Change of quality of Life

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

主要指标

Outcome:

Change of PD-related motor and non-motor symptoms

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

主要指标

Outcome:

Change of self-compassion

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

次要指标

Outcome:

Change of anxiety and depressive symptoms

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

次要指标

Outcome:

Change of Self-efficacy

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

次要指标

Outcome:

Change of perceived social support

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

次要指标

Outcome:

Change of constipation severity

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

次要指标

Outcome:

Change of bowel habits

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

次要指标

Outcome:

Change of gut microbiota composition

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

次要指标

Outcome:

User's satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

Fecal

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 100 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

Following the method of permuted block, participants will be randomly assigned into one of the two groups on a 1:1 ratio after completing baseline assessment. The random block size is 4 and 8. The allocation list will be computer-generated by an independent researcher who is not involved in the assessment. The same researcher will be responsible for informing the result to the participants. All outcome assessors will be blinded to subject allocation.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

Due to the nature of this trial, neither the staff, participants nor care provider can be masked to allocation. The data analyst will be blinded after study completion by having the intervention group information coded. All outcome assessors will be blinded to subject allocation.

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The data will be available upon request after the study period.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The study leader will be responsible for using a data management plan (DMP) to describe the use of data, and depositing a dataset in the University of Hong Kong Scholars Hub.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2023-10-24 16:17:51